Literature DB >> 18695170

Proton pump inhibitors: balancing the benefits and potential fracture risks.

J Brent Richards1, David Goltzman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18695170      PMCID： PMC2492957          DOI： 10.1503/cmaj.080873

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

Review 1.  Proton pump-inhibiting drugs, calcium homeostasis, and bone health.

Authors:  Matthew J Wright; Deborah D Proctor; Karl L Insogna; Jane E Kerstetter
Journal:  Nutr Rev       Date:  2008-02       Impact factor: 7.110

2.  Long-term proton pump inhibitor therapy and risk of hip fracture.

Authors:  Yu-Xiao Yang; James D Lewis; Solomon Epstein; David C Metz
Journal:  JAMA       Date:  2006-12-27       Impact factor: 56.272

3.  Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture.

Authors:  P Vestergaard; L Rejnmark; L Mosekilde
Journal:  Calcif Tissue Int       Date:  2006-08-15       Impact factor: 4.333

4.  Use of proton pump inhibitors and risk of osteoporosis-related fractures.

Authors:  Laura E Targownik; Lisa M Lix; Colleen J Metge; Heather J Prior; Stella Leung; William D Leslie
Journal:  CMAJ       Date:  2008-08-12       Impact factor: 8.262
  4 in total
  11 in total

Review 1.  Safety of the long-term use of proton pump inhibitors.

Authors:  Alan B R Thomson; Michel D Sauve; Narmin Kassam; Holly Kamitakahara
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

2.  Hip fracture and proton pump inhibitor therapy: position statement.

Authors:  Paul Moayyedi
Journal:  Can J Gastroenterol       Date:  2008-10       Impact factor: 3.522

3.  Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies.

Authors:  Chun-Sick Eom; Sang Min Park; Seung-Kwon Myung; Jae Moon Yun; Jeong-Soo Ahn
Journal:  Ann Fam Med       Date:  2011 May-Jun       Impact factor: 5.166

Review 4.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

5.  Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors.

Authors:  C Roux; J L Goldstein; X Zhou; A Klemes; R Lindsay
Journal:  Osteoporos Int       Date:  2011-03-02       Impact factor: 4.507

Review 6.  Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?

Authors:  Elizabeth M Haney; Stuart J Warden; M Michael Bliziotes
Journal:  Bone       Date:  2009-08-05       Impact factor: 4.398

7.  Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital.

Authors:  Kuntheavy Ing-Lorenzini; Jules Desmeules; Olivier Plachta; Domizio Suva; Pierre Dayer; Robin Peter
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 8.  Rabeprazole: a review of its use in the management of gastric acid-related diseases in adults.

Authors:  Claudine M Baldwin; Susan J Keam
Journal:  Drugs       Date:  2009-07-09       Impact factor: 9.546

Review 9.  Do proton pump inhibitors protect against cancer progression in GERD?

Authors:  Tomoharu Miyashita; Furhawn A Shah; John W Harmon; Guy P Marti; Daisuke Matsui; Koichi Okamoto; Isamu Makino; Hironori Hayashi; Katsunobu Oyama; Hisatoshi Nakagawara; Hidehiro Tajima; Hideto Fujita; Hiroyuki Takamura; Manabu Murakami; Itasu Ninomiya; Hirohisa Kitagawa; Sachio Fushida; Takashi Fujimura; Tetsuo Ohta
Journal:  Surg Today       Date:  2012-10-31       Impact factor: 2.549

10.  Peptic ulcer disease and heart disease are associated with periprosthetic fractures after total hip replacement.

Authors:  Jasvinder A Singh; David G Lewallen
Journal:  Acta Orthop       Date:  2012-08-20       Impact factor: 3.717
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.